{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:12:21Z","timestamp":1788840741796,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019217","name":"AlMaarefa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.coph.2026.102662","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:52:19Z","timestamp":1786171939000},"page":"102662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mitochondria as a therapeutic platform in inflammatory and degenerative disorders: mechanisms, biomarkers, and translational challenges"],"prefix":"10.1016","volume":"90","author":[{"given":"Lamiaa M.","family":"ElAbbasy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2026.102662_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1650938","article-title":"Editorial: recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging","volume":"19","author":"Sen","year":"2025","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.coph.2026.102662_sref2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","article-title":"Mitochondrial dysfunction: mechanisms and advances in therapy","volume":"9","author":"Zong","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.coph.2026.102662_bib3","article-title":"Cell-free mitochondrial DNA as a pro-inflammatory agent in blood circulation: mechanisms, therapeutic implications, and clinical challenges in immune dysregulation","volume":"16","author":"Zhao","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2026.102662_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13075-024-03438-y","article-title":"Correlation between circulating cell-free mitochondrial DNA content and severity of knee degeneration in patients with knee osteoarthritis: a cross-sectional study","volume":"26","author":"Wu","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coph.2026.102662_bib5","article-title":"Mitochondrial-targeted therapy for osteoarthritis: challenges and opportunities from basic research to clinical translation","volume":"17","author":"Zhang","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2026.102662_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70634","article-title":"From pharmacodynamic biomarker to evaluating treatment response: biomarkers in primary mitochondrial diseases","volume":"19","author":"Stern","year":"2026","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.coph.2026.102662_bib7","article-title":"Mitochondrial dysfunction unravels the potential molecular link between night shift work-related circadian disruption and elevated blood pressure in human and mouse models","volume":"19","author":"Jiang","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.coph.2026.102662_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12035-026-05760-9","article-title":"Targeting autophagy, ferroptosis, and neuroinflammation: Polyphenol-mediated modulation of emerging signaling pathways in neurodegeneration","volume":"63","author":"Jindal","year":"2026","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.coph.2026.102662_bib9","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X415585260303184042","article-title":"Mitochondrial function in neurons and glia in health and its alteration in parkinson's disease: a review","author":"Kaushik","year":"2026","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.coph.2026.102662_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s12035-026-06031-3","article-title":"Dissecting PANoptosis in the nervous system: a unified cell-death mechanism driving neuroimmune activation and chronic neuroinflammation","volume":"63","author":"Goel","year":"2026","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.coph.2026.102662_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.04.001","article-title":"Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling","volume":"100","author":"Brand","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.coph.2026.102662_sref12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","article-title":"Mitochondrial control of inflammation","volume":"23","author":"Marchi","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.coph.2026.102662_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/ijmm.2024.5371","article-title":"Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)","volume":"53","author":"Qin","year":"2024","journal-title":"Int J Mol Med."},{"key":"10.1016\/j.coph.2026.102662_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00439-011-1057-y","article-title":"Mitochondrial DNA and inflammatory diseases","volume":"131","author":"Escames","year":"2012","journal-title":"Hum Genet"},{"key":"10.1016\/j.coph.2026.102662_bib15","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202004029","article-title":"Mitophagy pathways in health and disease","volume":"219","author":"Killackey","year":"2020","journal-title":"J Cell Biol"},{"key":"10.1016\/j.coph.2026.102662_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2017.06.050","article-title":"Inflammation and mitochondrial dysfunction: a vicious circle in neurodegenerative disorders?","volume":"710","author":"van Horssen","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.coph.2026.102662_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2026.102115","article-title":"Mitochondrial dysfunction-induced PANoptosis: mechanisms, triggers, and disease implications","volume":"88","author":"Pan","year":"2026","journal-title":"Mitochondrion"},{"key":"10.1016\/j.coph.2026.102662_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/biomedicines14030682","article-title":"Mitochondrial dysfunction in the inflammatory process of neurodegenerative diseases","volume":"14","author":"Nesci","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.coph.2026.102662_bib19","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.coph.2026.102662_bib20","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/cimb47121042","article-title":"Mitochondrial dysfunction and metabolic reprogramming in chronic inflammatory diseases: molecular insights and therapeutic opportunities","volume":"47","author":"Kim","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.coph.2026.102662_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1159\/000533602","article-title":"Mitochondrial damage-associated molecular patterns and metabolism in the regulation of innate immunity","volume":"15","author":"Lyu","year":"2023","journal-title":"J Innate Immun"},{"key":"10.1016\/j.coph.2026.102662_sref22","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/brain\/awag037","article-title":"Mitochondrial DNA release and inflammation in mitochondrial disease pathogenesis","volume":"149","author":"Szabo","year":"2026","journal-title":"Brain"},{"key":"10.1016\/j.coph.2026.102662_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1186\/s12951-025-03667-6","article-title":"A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair","volume":"23","author":"Shi","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.coph.2026.102662_bib24","article-title":"MitoQ protects against oxidative stress-induced mitochondrial dysregulation in human cardiomyocytes","volume":"13","author":"Parker","year":"2025","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.coph.2026.102662_bib25","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.7150\/ijbs.95853","article-title":"Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.coph.2026.102662_bib26","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/biom15091242","article-title":"Inhibition of astrocyte reactivity by Mdivi-1 after status epilepticus in rats exacerbates microglia-mediated neuroinflammation and impairs limbic-cortical glucose metabolism","volume":"15","author":"G\u00f3mez-Oliver","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.coph.2026.102662_bib27","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/s41598-017-07181-0","article-title":"Mitochondrial division inhibitor-1 is neuroprotective in the A53T-\u03b1-synuclein rat model of Parkinson's disease","volume":"7","author":"Bido","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2026.102662_bib28","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.3390\/ijms23094776","article-title":"Targeting Sirt1, AMPK, Nrf2, CK2, and soluble guanylate cyclase with nutraceuticals: a practical strategy for preserving bone mass","volume":"23","author":"McCarty","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102662_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422686","article-title":"Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality","volume":"15","author":"Pang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2026.102662_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103782","article-title":"Involvement of NRF2 and AMPK signaling in aging and progeria: a digest","volume":"85","author":"Petsouki","year":"2025","journal-title":"Redox Biol"},{"key":"10.1016\/j.coph.2026.102662_bib31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/em.20554","article-title":"Mitochondria as a target in treatment","volume":"51","author":"Frantz","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.coph.2026.102662_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114927","article-title":"Biomimetic mitochondria-targeted drug delivery system for the treatment of inflammatory bowel disease","volume":"395","author":"Jia","year":"2026","journal-title":"J Contr Release"},{"key":"10.1016\/j.coph.2026.102662_bib33","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4103\/NRR.NRR-D-24-01507","article-title":"Inherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases","volume":"21","author":"Zhou","year":"2026","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.coph.2026.102662_bib34","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X446831260303200516","article-title":"Molecular mechanisms of dopaminergic neuron degeneration in Parkinson's disease: a comprehensive review","author":"Abubakar","year":"2026","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.coph.2026.102662_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132227","article-title":"Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease","volume":"410","author":"Baharvand","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.coph.2026.102662_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ard.2024.11.005","article-title":"Mitochondrial transplantation as a novel therapeutic approach in idiopathic inflammatory myopathy","volume":"84","author":"Kim","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coph.2026.102662_bib37","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.2174\/1381612820666140306103401","article-title":"Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases","volume":"20","author":"Wu","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.coph.2026.102662_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12979-023-00342-y","article-title":"Associations between circulating cell-free mitochondrial DNA, inflammatory markers, and cognitive and physical outcomes in community dwelling older adults","volume":"20","author":"Nidadavolu","year":"2023","journal-title":"Immun Ageing"},{"key":"10.1016\/j.coph.2026.102662_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1055","article-title":"Novel attributes of cell-free plasma mitochondrial DNA in traumatic injury","volume":"12","author":"Daly","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.coph.2026.102662_bib40","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1590\/s1678-9946202668006","article-title":"Circulating cell-free mitochondrial DNA as a candidate marker of hyperinflammation and immune activation in pre-adolescents, adolescents and young adults with COVID-19 and comorbidities","volume":"68","author":"Novo","year":"2026","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.coph.2026.102662_sref41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00325","article-title":"Biomarkers of mitochondrial disorders","volume":"21","author":"Shayota","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.coph.2026.102662_bib42","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.3390\/ijms26178216","article-title":"A perspective on the role of mitochondrial biomolecular condensates (mtBCs) in neurodegenerative diseases and evolutionary links to bacterial BCs","volume":"26","author":"Calcagnile","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102662_bib43","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.3390\/ijms22126396","article-title":"Plasma Gelsolin reinforces the diagnostic value of FGF-21 and GDF-15 for mitochondrial disorders","volume":"22","author":"Pe\u00f1as","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102662_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2026.1774015","article-title":"Cell-free mitochondrial DNA (cf-mtDNA) in human body fluids: molecular characteristics, release mechanisms, and clinical translation-an updated review","volume":"13","author":"Liu","year":"2026","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.coph.2026.102662_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70026","article-title":"The mitochondria-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic age","volume":"24","author":"Mitchell","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.coph.2026.102662_sref46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118056","article-title":"Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects","volume":"187","author":"Sabbah","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coph.2026.102662_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/02611929231157756","article-title":"Poor translatability of biomedical research using animals - a narrative review","volume":"51","author":"Marshall","year":"2023","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.coph.2026.102662_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/17425247.2025.2578369","article-title":"A multimodal perspective to overcome translational barriers in cerebrospinal drug delivery","volume":"23","author":"Kadamus","year":"2026","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.coph.2026.102662_bib49","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.3390\/pharmaceutics15112623","article-title":"Translational challenges and prospective solutions in the implementation of biomimetic delivery systems","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coph.2026.102662_bib50","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.3390\/ijms25094855","article-title":"Mitochondrial biomarkers in the omics era: a clinical-pathophysiological perspective","volume":"25","author":"Gervasoni","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102662_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2024.152865","article-title":"Mitochondrial DNA from endothelial cells activated the cGAS-STING pathway and regulated pyroptosis in lung ischaemia reperfusion injury after lung transplantation","volume":"230","author":"Ju","year":"2025","journal-title":"Immunobiology"},{"key":"10.1016\/j.coph.2026.102662_bib52","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/jnc.15798","article-title":"Improving neuropathic pain treatment - by rigorous stratification from bench to bedside","volume":"168","author":"Soliman","year":"2024","journal-title":"J Neurochem"},{"key":"10.1016\/j.coph.2026.102662_bib53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.anai.2020.01.013","article-title":"Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis","volume":"124","author":"Staudacher","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coph.2026.102662_bib54","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/mutage\/gead010","article-title":"Evaluation of endpoints for the study and diagnosis of mitochondrial toxicity and disease: a narrative review","volume":"38","author":"Gharti","year":"2023","journal-title":"Mutagenesis"},{"key":"10.1016\/j.coph.2026.102662_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00415-026-13794-1","article-title":"Non-invasive biomarkers for diagnosis and monitoring of primary mitochondrial diseases","volume":"273","author":"Arena","year":"2026","journal-title":"J Neurol"},{"key":"10.1016\/j.coph.2026.102662_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114629","article-title":"A Caspase-3 responsive nanoemulsion for targeted treatment of rheumatoid arthritis through dual modulation of inflammation and mitochondrial dysfunction","volume":"251","author":"Zhang","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.coph.2026.102662_bib57","article-title":"Recent development of mitochondrial metabolism and dysfunction in osteoarthritis","volume":"16","author":"Guo","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.coph.2026.102662_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157288","article-title":"Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response","volume":"148","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.coph.2026.102662_sref59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-024-02081-y","article-title":"Engineered mitochondria in diseases: mechanisms, strategies, and applications","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.coph.2026.102662_bib60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.coph.2026.102662_bib61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10522-025-10273-4","article-title":"Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategies","volume":"26","author":"Wei","year":"2025","journal-title":"Biogerontology"},{"key":"10.1016\/j.coph.2026.102662_bib62","doi-asserted-by":"crossref","first-page":"17159","DOI":"10.1007\/s00432-023-05376-9","article-title":"Multi-omics analysis revealed the mitochondrial-targeted drug combination to suppress the development of lung cancer","volume":"149","author":"Li","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.coph.2026.102662_bib63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s10916-026-02416-y","article-title":"DualKG-DC: a drug-centric dual-layer knowledge graph framework for drug combination prediction","volume":"50","author":"Gao","year":"2026","journal-title":"J Med Syst"},{"key":"10.1016\/j.coph.2026.102662_bib64","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s12276-023-00973-7","article-title":"Trends and prospects in mitochondrial genome editing","volume":"55","author":"Phan","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.coph.2026.102662_bib65","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1186\/s12967-025-07420-3","article-title":"Advances in gene therapy for mitochondrial genetic disorders: current status and clinical implementation challenges","volume":"23","author":"Lyu","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.coph.2026.102662_bib66","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1038\/s41467-025-61239-6","article-title":"Biotechnological approaches and therapeutic potential of mitochondria transfer and transplantation","volume":"16","author":"Kubat","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102662_bib67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jgr.2025.04.006","article-title":"Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model","volume":"49","author":"Pu","year":"2025","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.coph.2026.102662_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156982","article-title":"Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury","volume":"145","author":"Pu","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489226000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489226000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:03:39Z","timestamp":1788840219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489226000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S1471489226000585"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2026.102662","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria as a therapeutic platform in inflammatory and degenerative disorders: mechanisms, biomarkers, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2026.102662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102662"}}